Glucagon-like peptide-1 secretion in bulimia nervosaBRAMBILLA, Francesca; MONTELEONE, Palmiero; MAJ, Mario et al.Psychiatry research (Print). 2009, Vol 169, Num 1, pp 82-85, issn 0165-1781, 4 p.Article

Neural integration of satiation and food reward: Role of GLP-1 and orexin pathwaysWILLIAMS, Diana L.Physiology & behavior. 2014, Vol 136, pp 194-199, issn 0031-9384, 6 p.Conference Paper

Role of leptin in the regulation of glucagon-like peptide-1 secretionANINI, Younes; BRUBAKER, Patricia L.Diabetes (New York, NY). 2003, Vol 52, Num 2, pp 252-259, issn 0012-1797, 8 p.Article

THE ROLE Of GLP-1 IN NEURONAL ACTIVITY AND NEURODEGENERATIONHÖLSCHER, Christian.Vitamins and hormones. 2010, Vol 84, pp 331-354, issn 0083-6729, 24 p.Article

Glucagon-like peptide-1 inhibits glucagon-induced glycogenolysis in perivenous hepatocytes specificallyIKEZAWA, Yoshihiro; YAMATANI, Keiichi; OHNUMA, Hiroshi et al.Regulatory peptides. 2003, Vol 111, Num 1-3, pp 207-210, issn 0167-0115, 4 p.Article

Do current incretin mimetics exploit the full therapeutic potential inherent in GLP-1 receptor stimulation?NAUCK, M. A; BARANOV, O; RITZEL, R. A et al.Diabetologia (Berlin). 2013, Vol 56, Num 9, pp 1878-1883, issn 0012-186X, 6 p.Article

GLP-1 and GIP are colocalized in a subset of endocrine cells in the small intestineMORTENSEN, Kristine; CHRISTENSEN, Louise Lundby; HOLST, Jens Juul et al.Regulatory peptides. 2003, Vol 114, Num 2-3, pp 189-196, issn 0167-0115, 8 p.Article

Both GLP-1 and GIP are insulinotropic at basal and postprandial glucose levels and contribute nearly equally to the incretin effect of a meal in healthy subjectsVILSBØLL, Tina; KRARUP, Thure; MADSBAD, Sten et al.Regulatory peptides. 2003, Vol 114, Num 2-3, pp 115-121, issn 0167-0115, 7 p.Article

Identification of potent 11 mer Glucagon-Like Peptide-1 Receptor agonist peptides with novel C-terminal amino acids: Homohomophenylalanine analogsHAQUE, Tasir S; LEE, Ving G; EWING, William R et al.Peptides (New York, NY. 1980). 2010, Vol 31, Num 5, pp 950-955, issn 0196-9781, 6 p.Article

CENTRAL GLP-1 ACTIONS ON ENERGY METABOLISMVELASQUEZ, Douglas A; BEIROA, Daniel; VAZQUEZ, María J et al.Vitamins and hormones. 2010, Vol 84, pp 303-317, issn 0083-6729, 15 p.Article

Glucagon-Like Peptide (GLP)-1(9-36)Amide-Mediated Cytoprotection Is Blocked by Exendin(9-39) Yet Does Not Require the Known GLP-1 ReceptorBAN, Kiwon; KIM, Kyoung-Han; CHO, Chan-Kyung et al.Endocrinology (Philadelphia). 2010, Vol 151, Num 4, pp 1520-1531, issn 0013-7227, 12 p.Article

Agonistes du GLP-1: Les pistes pour un choix éclairé : EASD 2012: La SéléctionMOSNIER-PUDAR, Helen.Diabète & obésité. 2012, Vol 7, Num 63, pp 307-308, issn 1957-5238, 2 p.Article

Minireview: Update on Incretin Biology: Focus on Glucagon-Like Peptide-1BRUBAKER, Patricia L.Endocrinology (Philadelphia). 2010, Vol 151, Num 5, pp 1984-1989, issn 0013-7227, 6 p.Article

Glucagon-Like Peptide-1 Enhances Glucokinase Activity in Pancreatic β-Celis through the Association of Epac2 with Rim2 and Rab3APARK, Jae-Hyung; KIM, Sun-Joo; PARK, Sung-Hee et al.Endocrinology (Philadelphia). 2012, Vol 153, Num 2, pp 574-582, issn 0013-7227, 9 p.Article

Prior short-term consumption of resistant starch enhances postprandial insulin sensitivity in healthy subjectsROBERTSON, M. D; CURRIE, J. M; MORGAN, L. M et al.Diabetologia (Berlin). 2003, Vol 46, Num 5, pp 659-665, issn 0012-186X, 7 p.Article

Pancreatitis: A Potential Complication of Liraglutide?FRANKS, Andrea S; LEE, Phillip H; GEORGE, Christa M et al.The Annals of pharmacotherapy. 2012, Vol 46, Num 11, pp 1547-1553, issn 1060-0280, 7 p.Article

Insulin-independent effects of GLP-1 on canine liver glucose metabolism: duration of infusion and involvement of hepatoportal regionDARDEVET, D; MOORE, M. C; NEAL, D et al.American journal of physiology. Endocrinology and metabolism. 2004, Vol 50, Num 1, pp E75-E81, issn 0193-1849Article

Exendin-4 decreases amphetamine-induced locomotor activityERREGER, Kevin; DAVIS, Adeola R; POE, Amanda M et al.Physiology & behavior. 2012, Vol 106, Num 4, pp 574-578, issn 0031-9384, 5 p.Article

Effect of the artificial sweetener, sucralose, on small intestinal glucose absorption in healthy human subjectsJING MA; CHANG, Jessica; CHECKLIN, Helen L et al.British journal of nutrition. 2010, Vol 104, Num 6, pp 803-806, issn 0007-1145, 4 p.Article

GLP-1: Broadening the incretin concept to involve gut motilityHELLSTRÖM, Per M.Regulatory peptides. 2009, Vol 156, Num 1-3, pp 9-12, issn 0167-0115, 4 p.Article

Cyclic AMP triggers glucagon-like peptide-1 secretion from the GLUTag enteroendocrine cell lineSIMPSON, A. K; WARD, P. S; WONG, K. Y et al.Diabetologia (Berlin). 2007, Vol 50, Num 10, pp 2181-2189, issn 0012-186X, 9 p.Article

Intravenous CCK-8, but not GLP-1, suppresses ghrelin and stimulates PYY release in healthy menBRENNAN, Ixchel M; OTTO, Bärbel; FELTRIN, Kate L et al.Peptides (New York, NY. 1980). 2007, Vol 28, Num 3, pp 607-611, issn 0196-9781, 5 p.Article

Higher fasting plasma concentrations of glucagon-like peptide 1 are associated with higher resting energy expenditure and fat oxidation rates in humansPANNACCIULLI, Nicola; BUNT, Joy C; KOSKA, Juraj et al.The American journal of clinical nutrition. 2006, Vol 84, Num 3, pp 556-560, issn 0002-9165, 5 p.Article

Glucagon-like peptide 1: evolution of an incretin into a treatment for diabetesD'ALESSIO, David A; VAHL, Torsten P.American journal of physiology. Endocrinology and metabolism. 2004, Vol 49, Num 6, pp E882-E890, issn 0193-1849Article

Role of endogenous glucagon-like peptide-1 in islet regeneration after partial pancreatectomyDE LEON, Diva D; SHAOPING DENG; MADANI, Reza et al.Diabetes (New York, NY). 2003, Vol 52, Num 2, pp 365-371, issn 0012-1797, 7 p.Article